<DOC>
	<DOCNO>NCT01412177</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness OTO-104 treatment Meniere 's disease .</brief_summary>
	<brief_title>OTO-104 Treatment Meniere 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Meniere Disease</mesh_term>
	<criteria>Subject diagnosis unilateral Meniere 's disease 1995 American Academy Otolaryngology â€” Head Neck Surgery ( AAOHNS ) criterion report active vertigo 2 month prior study leadin period . Subject experience active vertigo leadin period . Subject document asymmetric sensorineural hearing loss . Subject agree maintain current treatment Meniere 's disease onstudy . Subjects currently lowsalt diet and/or diuretic time screen agree continue treatment throughout study . Subject pregnant lactating . Subject history immunodeficiency disease . Subject history previous endolymphatic sac surgery . Subject history previous use intratympanic ( IT ) gentamicin affect ear . Subject history tympanostomy tubes evidence perforation lack closure . Subject experience adverse reaction IT injection steroid . Subject use investigational drug device 3 month prior screen . Subject previously randomize trial OTO104 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Meniere 's Disease</keyword>
	<keyword>Vertigo</keyword>
	<keyword>Definitive vertigo</keyword>
	<keyword>Vertigo episode</keyword>
	<keyword>Vertigo frequency</keyword>
	<keyword>Tinnitus</keyword>
	<keyword>Hearing loss</keyword>
	<keyword>Aural fullness</keyword>
</DOC>